BioCentury | Nov 16, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...multiple-antigen cargo. Amal Therapeutics S.A., Geneva, Switzerland Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech Gruenderfonds Schroder...
BioCentury | Nov 12, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...agonist adjuvant and a modulable multiple-antigen cargo. Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech Gruenderfonds Schroder...
BioCentury | Oct 3, 2016
Financial News

Immunic completes venture financing

...2016-09-27 Type: Venture financing Raised: EUR17.5 million ($19.7 million) Investors: LSP; LifeCare Partners; Bayern Kapital; High-Tech Gruenderfonds...
BioCentury | Sep 27, 2016
Financial News

Immunic raises EUR 17.5M in series A round

...$19.7 million) in a series A round led by LSP and LifeCare Partners. Bayern Kapital, High-Tech Gruenderfonds...
BioCentury | Sep 12, 2016
Financial News

Rigontec financial update

...round to EUR29.3 million ($33.9 million). Existing investors Boehringer Ingelheim Venture Fund; Forbion Capital Partners; High-Tech Gruenderfonds...
BioCentury | Sep 12, 2016
Finance

To B, or not to B

...unveils tox data for lead product RGT100 . Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gruenderfonds...
BioCentury | Sep 6, 2016
Financial News

Rigontec raises EUR 15M for RIG-I agonists

...close of its series A round. Existing investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gruenderfonds...
BioCentury | Apr 4, 2016
Financial News

Amal Therapeutics completes venture financing

...Type: Venture financing Raised: CHF3 million ($3.1 million) Investors: Boehringer Ingelheim Venture Fund; VI Partners; High-Tech Gruenderfonds WIR...
BioCentury | May 4, 2015
Financial News

cytena completes venture financing

...Germany Business: Supply/Service Date completed: 2015-04-29 Type: Venture financing Raised: EUR1.1 million ($1.2 million) Investors: High-Tech Gruenderfonds...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

...financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners; SMS Investments; VC Fonds Berlin; High-Tech Gruenderfonds...
Items per page:
1 - 10 of 24
BioCentury | Nov 16, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...multiple-antigen cargo. Amal Therapeutics S.A., Geneva, Switzerland Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech Gruenderfonds Schroder...
BioCentury | Nov 12, 2018
Financial News

Swiss cancer play Amal eyes clinic following €21.2M tranche

...agonist adjuvant and a modulable multiple-antigen cargo. Jaime De Leon Amal Therapeutics S.A. BioMedPartners Boehringer Ingelheim Venture Fund Helsinn Investment Fund High-Tech Gruenderfonds Schroder...
BioCentury | Oct 3, 2016
Financial News

Immunic completes venture financing

...2016-09-27 Type: Venture financing Raised: EUR17.5 million ($19.7 million) Investors: LSP; LifeCare Partners; Bayern Kapital; High-Tech Gruenderfonds...
BioCentury | Sep 27, 2016
Financial News

Immunic raises EUR 17.5M in series A round

...$19.7 million) in a series A round led by LSP and LifeCare Partners. Bayern Kapital, High-Tech Gruenderfonds...
BioCentury | Sep 12, 2016
Financial News

Rigontec financial update

...round to EUR29.3 million ($33.9 million). Existing investors Boehringer Ingelheim Venture Fund; Forbion Capital Partners; High-Tech Gruenderfonds...
BioCentury | Sep 12, 2016
Finance

To B, or not to B

...unveils tox data for lead product RGT100 . Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gruenderfonds...
BioCentury | Sep 6, 2016
Financial News

Rigontec raises EUR 15M for RIG-I agonists

...close of its series A round. Existing investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gruenderfonds...
BioCentury | Apr 4, 2016
Financial News

Amal Therapeutics completes venture financing

...Type: Venture financing Raised: CHF3 million ($3.1 million) Investors: Boehringer Ingelheim Venture Fund; VI Partners; High-Tech Gruenderfonds WIR...
BioCentury | May 4, 2015
Financial News

cytena completes venture financing

...Germany Business: Supply/Service Date completed: 2015-04-29 Type: Venture financing Raised: EUR1.1 million ($1.2 million) Investors: High-Tech Gruenderfonds...
BioCentury | Apr 20, 2015
Financial News

Omeicos Therapeutics completes venture financing

...financing Raised: EUR6.2 million ($6.5 million) Investors: Vesalius Biocapital Partners; SMS Investments; VC Fonds Berlin; High-Tech Gruenderfonds...
Items per page:
1 - 10 of 24